Pfizer Inc applied to U.S. health regulators on Friday for emergency use authorization (EUA) of its COVID-19 vaccine, the first such application in a major step toward providing protection against the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback